Detection of Early Renal Damage using Serum Cystatin-C in Transfusion Dependent Thalassemia Syndrome Patients

Authors

  • Sobia Bashir Institute of Basic Medical Sciences Khyber Medical University, Peshawar, Pakistan
  • Nazish Farooq Khyber Medical College, Peshawar, Pakistan
  • Muhammad Tariq Masood Northwest Medical College Peshawar, Pakistan
  • Nayab Farid Institute of Basic Medical Sciences Khyber Medical University, Peshawar, Pakistan
  • Aamir Khan Institute of Pathology and Diagnostic Medicine, Khyber Medical University Peshawar, Pakistan
  • Mahwish Nowshad IBMS,KMU

DOI:

https://doi.org/10.35845/abms.2023.2.272

Keywords:

Transfusion dependent thalassemia, Thalassemia Major, Renal functions, serum Creatinine, Serum cystatin-C, Glomerular filtration rate

Abstract

Background: Transfusion-dependent thalassemia (TDT) patients suffer from several life-threatening complications. These mainly stem from iron overload, a common adverse effect of regular transfusions. Studies discerning renal complications are, however, scarce.

Objective: This study investigatesthe frequency of early renal damage among TDT patients using serum cystatin-C. The relationship between serum cystatin-Cand serum ferritin levels is also elucidated.

Design: Cross-sectional study

Place & duration of study: Khyber Medical University, May 2019 to January 2020

Methodology:Known TDT patients, 3 to 16 years of age, were enrolled in the study.Biochemical tests were conducted on the blood and urine samples of the patients. Data was entered and analyzed for statistical significance.

Results:In pediatric TDT patients, serum cystatin-C was significantly higher, while serum creatinine and estimated glomerular filtration rate (eGFR)were within the normal range when compared to controls. A positive correlation was identified between serum cystatin-Cand serum ferritin. Similarly, Serum cystatin-Cwas found to have a positive correlation with pretransfusion hemoglobin.The interval of transfusion was, however, inversely associated with serum cystatin-C levels.

Conclusion:Asymptomatic renal dysfunction is found in TDT patients. Thismay be attributed to iron overload.

Keywords:Transfusion dependent thalassemia, Thalassemia Major, Renal functions, serum Creatinine, Serum cystatin-C, Glomerular filtration rate

References

H.W. Goonasekera, C.S. Paththinige, V.H.W. Dissanayake, Population Screening for Hemoglobinopathies, Annu. Rev. Genomics Hum. Genet. 19 (2018) 355–380. https://doi.org/10.1146/ANNUREV-GENOM-091416-035451.

F. Fazal, M. Arshad, H. Mustafa, M.E.U. Rehman, U. Tanveer, S. Hamid, Assessment of level of Awareness regarding Thalassemia Major among Parents of Affected Children, J. Rawalpindi Med. Coll. 25 (2021) 3–7. https://doi.org/10.37939/JRMC.V25I1.1736.

R. Origa, β-Thalassemia, Genet. Med. 19 (2017) 609–619. https://doi.org/10.1038/GIM.2016.173.

B. Deveci, A. Kurtoglu, E. Kurtoglu, O. Salim, T. Toptas, Documentation of renal glomerular and tubular impairment and glomerular hyperfiltration in multitransfused patients with beta thalassemia, Ann. Hematol. 95 (2016) 375–381. https://doi.org/10.1007/S00277-015-2561-2/TABLES/4.

C. Demosthenous, E. Vlachaki, C. Apostolou, P. Eleftheriou, A. Kotsiafti, E. Vetsiou, E. Mandala, V. Perifanis, P. Sarafidis, Beta-thalassemia: renal complications and mechanisms: a narrative review, Hematology. 24 (2019) 426–438. https://doi.org/10.1080/16078454.2019.1599096.

D.B. Duarte, M.C.S.R. Lacerda, Y.J.P. Ribeiro, M.Z.D. Ribeiro, M. de A. Frederico, M.J.C. Oliveira, Kidney biomarkers in tropical infections: an update, Pathog. Glob. Health. 114 (2020) 302–308. https://doi.org/10.1080/20477724.2020.1799605.

M. Yaghobi, E. Miri-Moghaddam, N. Majid, A. Bazi, A. Navidian, A. Kalkali, Complications of Transfusion-Dependent β-Thalassemia Patients in Sistan and Baluchistan, South-East of Iran, Int. J. Hematol. Stem Cell Res. 11 (2017) 268. /labs/pmc/articles/PMC5767285/ (accessed March 8, 2022).

C.T. Quinn, V.L. Johnson, H.Y. Kim, F. Trachtenberg, M.G. Vogiatzi, J.L. Kwiatkowski, E.J. Neufeld, E. Fung, N. Oliveri, M. Kirby, P.J. Giardina, Renal dysfunction in patients with thalassaemia, Br. J. Haematol. 153 (2011) 111–117. https://doi.org/10.1111/J.1365-2141.2010.08477.X.

D. Hanna, M. Beshir, N. Khalifa, E. Baz, A. Elhewala, Assessment of cystatin C in pediatric sickle cell disease and β-thalassemia as a marker of subclinical cardiovascular dysfunction: a case-control study, Pediatr. Hematol. Oncol. 38 (2021) 620–632. https://doi.org/10.1080/08880018.2021.1894280.

E.A. Hamed, N.T. ElMelegy, Renal functions in pediatric patients with beta-thalassemia major: relation to chelation therapy: original prospective study., Ital. J. Pediatr. 36 (2010) 39. https://doi.org/10.1186/1824-7288-36-39/TABLES/5.

J. Macdonald, S. Marcora, M. Jibani, G. Roberts, M. Kumwenda, R. Glover, J. Barron, A. Lemmey, GFR Estimation Using Cystatin C Is Not Independent of Body Composition, Am. J. Kidney Dis. 48 (2006) 712–719. https://doi.org/10.1053/J.AJKD.2006.07.001.

G.B. Forbes, Human Body Composition: Growth, Aging, Nutrition, and Activity, Springer Sci. Bus. Media; (2012). https://books.google.com.hk/books?hl=en&lr=&id=A9XTBwAAQBAJ&oi=fnd&pg=PA1&dq=Human+body+composition:+growth,+aging,+nutrition,+and+activity&ots=mnXytHYJfX&sig=4wcAZoWcqcNxEThReOCEMr1S1uI&redir_esc=y#v=onepage&q=Human body composition%3A growth%2C aging%2C (accessed March 8, 2022).

A.G. Kacar, I. Silfeler, A. Kacar, F. Pekun, E. Turkkan, E. Adal, Beta Talasemi Major hastalarında beta-2 mikroglobulin ve sistatin c düzeyleri, J. Clin. Anal. Med. 6 (2015) 269–273. https://doi.org/10.4328/JCAM.1968.

O.G. Behairy, E.R. Abd Almonaem, N.T. Abed, O.M. Abdel Haiea, R.M. Zakaria, R.I. AbdEllaty, E.H. Asr, A.I. Mansour, A.M.N. Abdelrahman, H.A. Elhady, Role of serum cystatin-C and beta-2 microglobulin as early markers of renal dysfunction in children with beta thalassemia major, Int. J. Nephrol. Renovasc. Dis. 10 (2017) 261. https://doi.org/10.2147/IJNRD.S142824.

A.A. Mahmoud, D.M. Elian, N.M.S. Abd El Hady, H.M. Abdallah, S. Abdelsattar, F.O. Khalil, S.A. Abd El Naby, Assessment of Subclinical Renal Glomerular and Tubular Dysfunction in Children with Beta Thalassemia Major, Children. 8 (2021) 100. https://doi.org/10.3390/CHILDREN8020100.

J.M. Hilderink, N. Van Der Linden, D.M. Kimenai, E.J.R. Litjens, L.J.J. Klinkenberg, B.M. Aref, F. Aziz, J.P. Kooman, R.J.M.W. Rennenberg, O. Bekers, R.P. Koopmans, S.J.R. Meex, Biological Variation of Creatinine, Cystatin C, and eGFR over 24 Hours, Clin. Chem. 64 (2018) 851–860. https://doi.org/10.1373/CLINCHEM.2017.282517.

B.A. Ali, A.M. Mahmoud, Frequency of Glomerular Dysfunction in Children with Beta Thalassaemia Major, Sultan Qaboos Univ. Med. J. 14 (2014) e88. https://doi.org/10.12816/0003341.

D. Ali, K. Mehran, A.G. Moghaddam, Saudi Journal of Kidney Diseases and Transplantation, Saudi J. Kidney Dis. Transplant. 19 (2008) 206. https://www.sjkdt.org/article.asp?issn=1319-2442;year=2008;volume=19;issue=2;spage=206;epage=209;aulast=Ali (accessed March 8, 2022).

A. Annayev, Z. Karakaş, S. Karaman, A. Yalçıner, A. Yılmaz, S. Emre, Glomerular and Tubular Functions in Children and Adults with Transfusion-Dependent Thalassemia, Turkish J. Hematol. 35 (2018) 66. https://doi.org/10.4274/TJH.2017.0266.

A.N. Mian, G.J. Schwartz, Measurement and Estimation of Glomerular Filtration Rate in Children, Adv. Chronic Kidney Dis. 24 (2017) 348–356. https://doi.org/10.1053/J.ACKD.2017.09.011.

O. Tanous, Y. Azulay, R. Halevy, T. Dujovny, N. Swartz, R. Colodner, A. Koren, C. Levin, Renal function in β-thalassemia major patients treated with two different iron-chelation regimes, BMC Nephrol. 22 (2021) 1–11. https://doi.org/10.1186/S12882-021-02630-5/FIGURES/7.

G. Milo, R.F.G. Nevo, I. Pazgal, A. Gafter-Gvili, O. Shpilberg, U. Gafter, A. Erman, P. Stark, GFR in Patients with β-Thalassemia Major, Clin. J. Am. Soc. Nephrol. 10 (2015) 1350–1356. https://doi.org/10.2215/CJN.12181214.

E. Uzun, Y.I. Balcı, S. Yüksel, Z. Aral, H. Aybek, B. Akdağ, Y. I¸sık, I. Balcı, S. Yü Ksel, Y.Z. Aral, H. Lya Aybek, B. Akdag, Glomerular and tubular functions in children with different forms of beta thalassemia, Ren. Fail. 37 (2015) 1414–1418. https://doi.org/10.3109/0886022X.2015.1077314.

M. Zafari, A. Aghamohammady, M. Mosavy, Renal function in Thalassemia major patients who treated by Desferal, Bangladesh J. Med. Sci. 17 (2018) 58–61. https://doi.org/10.3329/BJMS.V17I1.35281.

A.A.M. Adly, D.N. Toaima, N.R. Mohamed, K.M. Abu El Seoud, Subclinical renal abnormalities in young thalassemia major and intermedia patients and its relation to chelation therapy, Egypt. J. Med. Hum. Genet. 15 (2014) 369–377. https://doi.org/10.1016/J.EJMHG.2014.06.004.

Downloads

Published

2023-12-31

How to Cite

1.
Bashir S, Farooq N, Masood MT, Farid N, Khan A, Nowshad M. Detection of Early Renal Damage using Serum Cystatin-C in Transfusion Dependent Thalassemia Syndrome Patients. Adv Basic Med Sci [Internet]. 2023Dec.31 [cited 2024Nov.7];7(2):51-5. Available from: https://abms.kmu.edu.pk/index.php/abms/article/view/272